Literature DB >> 8392894

Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice.

L Menendez1, F Andres-Trelles, A Hidalgo, A Baamonde.   

Abstract

We have studied the effects of several opioid antagonists on a type of footshock stress-induced analgesia (FSIA) measured by the tail-flick test in male mice. Naloxone injected either subcutaneously (0.1-10 mg/kg) or intrathecally (1-20 micrograms) antagonized FSIA at higher doses than those that blocked a similar degree of analgesia induced by morphine. Intracerebroventricular (i.c.v.) naloxone (1-20 micrograms) did not modify the FSIA while antagonizing the i.c.v. morphine-induced analgesia. As a consequence, the antagonism of the FSIA by naloxone probably occurs at the level of the spinal cord and through receptors different than mu. The delta selective antagonist naltrindole (0.1-3 mg/kg s.c.) did not antagonize the analgesic effects of the stress. Nor-binaltorphimine, a kappa selective antagonist, blocked the FSIA when administered systemically (1-4 mg/kg i.p.) or locally (0.1-1 microgram i.t.). These results strongly suggest that spinal kappa opioid receptors are responsible for this type of endogenous analgesia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392894     DOI: 10.1016/0006-8993(93)90512-l

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats.

Authors:  Patrick M Beardsley; Gerald T Pollard; James L Howard; F Ivy Carroll
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

Review 2.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

3.  Estrogens as arbiters of sex-specific and reproductive cycle-dependent opioid analgesic mechanisms.

Authors:  Alan R Gintzler; Emiliya M Storman; Nai-Jiang Liu
Journal:  Vitam Horm       Date:  2019-07-02       Impact factor: 3.421

4.  Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats.

Authors:  Patrick M Beardsley; James L Howard; Keith L Shelton; F Ivy Carroll
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

5.  T-Cell Mediation of Pregnancy Analgesia Affecting Chronic Pain in Mice.

Authors:  Sarah F Rosen; Boram Ham; Shannon Drouin; Nadia Boachie; Anne-Julie Chabot-Dore; Jean-Sebastien Austin; Luda Diatchenko; Jeffrey S Mogil
Journal:  J Neurosci       Date:  2017-09-06       Impact factor: 6.167

6.  κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain.

Authors:  Salim Megat; Yohann Bohren; Stephane Doridot; Claire Gaveriaux-Ruff; Brigitte L Kieffer; Marie-José Freund-Mercier; Ipek Yalcin; Michel Barrot
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

7.  Sensitivity to μ-opioid receptor-mediated anti-nociception is determined by cross-regulation between μ- and δ-opioid receptors at supraspinal level.

Authors:  J J Ballesta; J Cremades; M Rodríguez-Muñoz; J Garzón; C C Faura
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

8.  Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.

Authors:  Jay P McLaughlin; Monica Marton-Popovici; Charles Chavkin
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

Review 9.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

10.  KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.

Authors:  Paige M Estave; Mary B Spodnick; Anushree N Karkhanis
Journal:  Handb Exp Pharmacol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.